Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-07-08

FDA Approved: NICOTINE — Original Application (P & L Development, LLC)

View source ↗

Summary

FDA approved NICOTINE POLACRILEX (nicotine polacrilex lozenges) from P & L Development, LLC under an original application (ANDA079044).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NICOTINE POLACRILEX (nicotine polacrilex)

Snippet

ORIG AP for NICOTINE (NICOTINE POLACRILEX)